Cell-based Biological Pacemakers: Progress and Problems

被引:0
|
作者
Saito, Yukihiro [1 ]
Nakamura, Kazufumi [1 ]
Ito, Hiroshi [1 ]
机构
[1] Okayama Univ, Grad Sch Med Dens & Pharmaceut Sci, Dept Cardiovasc Med, Okayama 7008558, Japan
关键词
cell therapy; pluripotent stem cells; cardiomyocytes; biological pacemaker; hyperpolarization activated cyclic nucleotide gated potassium channel 4; MESENCHYMAL STEM-CELLS; GENE-TRANSFER; CARDIOMYOCYTES; DIFFERENTIATION; SINOATRIAL; CHANNELS; INTEGRATION; DELIVERY; SHOX2; OVEREXPRESSION;
D O I
暂无
中图分类号
R-3 [医学研究方法]; R3 [基础医学];
学科分类号
1001 ;
摘要
The number of permanent pacemaker implantations has been increasing due to the aging of populations worldwide and the increase in the numbers of patients with heart diseases. Commercially available mechanical pacemakers are very useful but still have some problems including short battery life, a risk of infection, the absence of physiological autonomic responsiveness, metal allergy, and electronic interference. A biological pacemaker may resolve these problems and regenerate the cardiac pacemaker. Cell-based therapy and gene therapy have been addressed with the goal of solving the challenges of biological pacemaker. However, the clinical application of a biological pacemaker has not yet been realized. Here we discuss the types of cells that can be used for a biological pacemaker and the problems that remain regarding the clinical applications of cell-based therapy.
引用
收藏
页码:1 / 7
页数:7
相关论文
共 50 条
  • [1] Stem cell-based biological pacemakers from proof of principle to therapy: a review
    Chauveau, Samuel
    Brink, Peter R.
    Cohen, Ira S.
    CYTOTHERAPY, 2014, 16 (07) : 873 - 880
  • [2] Biological pacemakers based on If
    Michael R. Rosen
    Peter R. Brink
    Ira S. Cohen
    Richard B. Robinson
    Medical & Biological Engineering & Computing, 2007, 45 : 157 - 166
  • [3] Biological pacemakers based on If
    Rosen, Michael R.
    Brink, Peter R.
    Cohen, Ira S.
    Robinson, Richard B.
    MEDICAL & BIOLOGICAL ENGINEERING & COMPUTING, 2007, 45 (02) : 157 - 166
  • [4] DNT Cell-based Immunotherapy: Progress and Applications
    Li, Yingrui
    Dong, Kang
    Fan, Xueke
    Xie, Jun
    Wang, Miao
    Fu, Songtao
    Li, Qin
    JOURNAL OF CANCER, 2020, 11 (13): : 3717 - 3724
  • [5] Progress in cell-based therapies for tendon repair
    Gaspar, Diana
    Spanoudes, Kyriakos
    Holladay, Carolyn
    Pandit, Abhay
    Zeugolis, Dimitrios
    ADVANCED DRUG DELIVERY REVIEWS, 2015, 84 : 240 - 256
  • [6] Cell-based influenza vaccines: Progress to date
    Audsley, Jennifer M.
    Tannock, Gregory A.
    DRUGS, 2008, 68 (11) : 1483 - 1491
  • [7] Stem cell-based biological vascular replacement
    Gasser, M.
    Frank, M. H.
    Waaga-Gasser, A. M.
    GEFASSCHIRURGIE, 2018, 23 (01): : 28 - 33
  • [8] Cell-based microarrays: current progress, future prospects
    Palmer, E
    Freeman, T
    PHARMACOGENOMICS, 2005, 6 (05) : 527 - 534
  • [9] γδ T cell-based anticancer immunotherapy: progress and possibilities
    Meraviglia, Serena
    Lo Presti, Elena
    Dieli, Francesco
    Stassi, Giorgio
    IMMUNOTHERAPY, 2015, 7 (09) : 949 - 951
  • [10] Progress and challenges in the development of a cell-based therapy for hemophilia A
    Fomin, M. E.
    Togarrati, P. P.
    Muench, M. O.
    JOURNAL OF THROMBOSIS AND HAEMOSTASIS, 2014, 12 (12) : 1954 - 1965